X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Safe and effective prescribing: A new and important initiative from the PhRMA Foundation

By Eileen Cannon  |    September 26, 2018
Safe and effective prescribing is a critically important part of the equation for successful medical treatment in today’s health care system. Yet data from the Association of American Colleges...   Read More

PhRMA comments in response to request for information on competitive bidding program in Medicare Part B

By Nicole Longo  |    September 25, 2018
Yesterday, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the recent 2019 Hospital Outpatient Prospective Payment System proposed rule,...   Read More

New report shows more than 300 skin disease medicines in development

By Andrew Powaleny  |    September 25, 2018
More than 100 million Americans – one third of the U.S. population – suffer from skin conditions.   Read More

Experts agree: the Bipartisan Budget Act changes to Medicare Part D jeopardize the program

By Juliet Johnson  |    September 24, 2018
The changes made to Part D in the Bipartisan Budget Act (BBA) that passed in February threaten the program’s successful competitive structure. While these changes closed the donut hole a year...   Read More

Five myths about global efforts to combat tuberculosis

By Megan Van Etten  |    September 20, 2018
On September 26, world leaders will convene in New York for the first-ever United Nations (UN) High-Level Meeting on Ending Tuberculosis (TB). This event could not be more critical – or more...   Read More

New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers

By Lauren Neves  |    September 19, 2018
A new whitepaper authored by Bruce Pyenson, F.S.A., M.A.A.A. and colleagues from Milliman explains why Institute for Clinical and Economic Review (ICER) cost-effective analyses (CEAs) will not be...   Read More

Saving kids and dogs from shared cancers

By Guest Contributor  |    September 17, 2018
Ulrike Szalay is the Founder and Executive Director of Canines-N-Kids Foundation Did you know? Dogs and children spontaneously develop a number of similar cancers. In fact, cancer is the leading...   Read More

What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?

By Juliet Johnson  |    September 13, 2018
Right now, Congress has the opportunity to make two small fixes that will protect seniors in the Medicare Part D donut hole and save them money on out-of-pocket costs for their medicines.  These...   Read More

New report details the setbacks and challenges to Alzheimer’s research

By Gretta Stone  |    September 12, 2018
Illustrating the challenges of developing medicines to fight Alzheimer’s disease, a new analysis found that between 1998 and 2017, there were 146 unsuccessful medicines in clinical trials for...   Read More

Disrupting Alzheimer's

By Andrew Powaleny  |    September 10, 2018
We are living in a new era of medicine, where treatments and even cures once believed to be impossible are today a reality. But this immense progress does not apply universally and there have been...   Read More

Guest post: Developing new payment models to ensure patients have access to high-investment therapies

By Guest Contributor  |    September 6, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

New study finds some hospitals mark up medicine prices at least 700 percent

By Holly Campbell  |    September 5, 2018
A new analysis from The Moran Company found nearly one in five hospitals marks up medicine prices 700 percent or more. With this 700 percent markup, a $150 medicine purchased by a hospital could...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates